Fingerprint
Dive into the research topics of 'Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically